Lucid Diagnostics Statistics
Share Statistics
Lucid Diagnostics has 105.38M
shares outstanding. The number of shares has increased by 65.7%
in one year.
Shares Outstanding | 105.38M |
Shares Change (YoY) | 65.7% |
Shares Change (QoQ) | 46.36% |
Owned by Institutions (%) | 6.57% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 13,211 |
FTD / Avg. Volume | 1.18% |
Short Selling Information
The latest short interest is 1.6M, so 1.52% of the outstanding
shares have been sold short.
Short Interest | 1.6M |
Short % of Shares Out | 1.52% |
Short % of Float | 2.29% |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.91 and the forward
PE ratio is -3.62.
Lucid Diagnostics's PEG ratio is
0.02.
PE Ratio | -0.91 |
Forward PE | -3.62 |
PS Ratio | 9.52 |
Forward PS | 2.2 |
PB Ratio | 0.01 |
P/FCF Ratio | -0.92 |
PEG Ratio | 0.02 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Lucid Diagnostics.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1069.04,
with a Debt / Equity ratio of 3.94.
Current Ratio | 1069.04 |
Quick Ratio | 1069.02 |
Debt / Equity | 3.94 |
Debt / EBITDA | -479.38 |
Debt / FCF | -474.57 |
Interest Coverage | -1771.23 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $60,361.11 |
Profits Per Employee | $-632,347.22 |
Employee Count | 72 |
Asset Turnover | 0.14 |
Inventory Turnover | 20.82 |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 29.07% in the
last 52 weeks. The beta is 1.28, so Lucid Diagnostics's
price volatility has been higher than the market average.
Beta | 1.28 |
52-Week Price Change | 29.07% |
50-Day Moving Average | 1.36 |
200-Day Moving Average | 1.02 |
Relative Strength Index (RSI) | 40.87 |
Average Volume (20 Days) | 1,117,091 |
Income Statement
In the last 12 months, Lucid Diagnostics had revenue of 4.35M
and earned -45.53M
in profits. Earnings per share was -0.75.
Revenue | 4.35M |
Gross Profit | -2.75M |
Operating Income | -46.05M |
Net Income | -45.53M |
EBITDA | -44.34M |
EBIT | -45.5M |
Earnings Per Share (EPS) | -0.75 |
Full Income Statement Balance Sheet
The company has 22.36B in cash and 21.25B in
debt, giving a net cash position of 1.1B.
Cash & Cash Equivalents | 22.36B |
Total Debt | 21.25B |
Net Cash | 1.1B |
Retained Earnings | -203.77B |
Total Assets | 30.71M |
Working Capital | 1.62M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -44.14M
and capital expenditures 0, giving a free cash flow of -44.79M.
Operating Cash Flow | -44.14M |
Capital Expenditures | n/a |
Free Cash Flow | -44.79M |
FCF Per Share | -0.89 |
Full Cash Flow Statement Margins
Gross margin is -63.35%, with operating and profit margins of -1059.64% and -1047.61%.
Gross Margin | -63.35% |
Operating Margin | -1059.64% |
Pretax Margin | -1047.61% |
Profit Margin | -1047.61% |
EBITDA Margin | -1020.16% |
EBIT Margin | -1059.64% |
FCF Margin | -1030.51% |